Lansion Biotechnology Co., Ltd. (Lansionbio), founded in 2016 in Nanjing, China, is a high-tech enterprise specializing in the research, development, production, sales, and service of in vitro diagnostic reagents and devices. The company offers integrated, multi-platform POCT (Point-of-Care Testing) solutions, providing medical facilities and homes with rapid on-site testing capabilities. Lansionbio has become a leading player in China's laboratory medicine sector. Since 2020, it has actively contributed to global COVID-19 prevention and control efforts, with its certified products exported to over 50 countries and regions worldwide.